SI0983271T1 - Carbocyclic nucleoside hemisulfate and its use in treating viral infections - Google Patents

Carbocyclic nucleoside hemisulfate and its use in treating viral infections

Info

Publication number
SI0983271T1
SI0983271T1 SI9830615T SI9830615T SI0983271T1 SI 0983271 T1 SI0983271 T1 SI 0983271T1 SI 9830615 T SI9830615 T SI 9830615T SI 9830615 T SI9830615 T SI 9830615T SI 0983271 T1 SI0983271 T1 SI 0983271T1
Authority
SI
Slovenia
Prior art keywords
viral infections
treating viral
carbocyclic nucleoside
hemisulfate
nucleoside hemisulfate
Prior art date
Application number
SI9830615T
Other languages
English (en)
Slovenian (sl)
Inventor
Alastair Couper Brodie
Martin Francis Jones
John Frederick Seager
Christopher John Wallis
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10812407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0983271(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of SI0983271T1 publication Critical patent/SI0983271T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
SI9830615T 1997-05-17 1998-05-14 Carbocyclic nucleoside hemisulfate and its use in treating viral infections SI0983271T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt
EP98925601A EP0983271B1 (en) 1997-05-17 1998-05-14 Carbocyclic nucleoside hemisulfate and its use in treating viral infections
PCT/EP1998/002835 WO1998052949A1 (en) 1997-05-17 1998-05-14 Carbocyclic nucleoside hemisulfate and its use in treating viral infections

Publications (1)

Publication Number Publication Date
SI0983271T1 true SI0983271T1 (en) 2004-06-30

Family

ID=10812407

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830615T SI0983271T1 (en) 1997-05-17 1998-05-14 Carbocyclic nucleoside hemisulfate and its use in treating viral infections

Country Status (51)

Country Link
US (1) US6294540B1 (zh)
EP (1) EP0983271B1 (zh)
JP (2) JP3150711B2 (zh)
KR (1) KR100521292B1 (zh)
CN (2) CN100408580C (zh)
AP (1) AP2009A (zh)
AR (2) AR015668A1 (zh)
AT (1) ATE259811T1 (zh)
AU (1) AU739953B2 (zh)
BG (1) BG64390B1 (zh)
BR (1) BRPI9809126B8 (zh)
CA (1) CA2289753C (zh)
CO (1) CO4940435A1 (zh)
DE (1) DE69821758T2 (zh)
DK (1) DK0983271T3 (zh)
DZ (1) DZ2493A1 (zh)
EA (1) EA001809B1 (zh)
EE (1) EE03924B1 (zh)
EG (1) EG23836A (zh)
ES (1) ES2214712T3 (zh)
GB (3) GB9709945D0 (zh)
GE (1) GEP20022680B (zh)
HK (1) HK1024236A1 (zh)
HN (1) HN1998000071A (zh)
HR (1) HRP980265B1 (zh)
HU (1) HU226563B1 (zh)
ID (1) ID24910A (zh)
IL (2) IL132793A0 (zh)
IS (1) IS2207B (zh)
JO (1) JO2032B1 (zh)
MA (1) MA26498A1 (zh)
MY (1) MY120151A (zh)
NO (1) NO324731B1 (zh)
NZ (2) NZ510622A (zh)
OA (1) OA11304A (zh)
PA (1) PA8451301A1 (zh)
PE (1) PE78799A1 (zh)
PL (1) PL189527B1 (zh)
PT (1) PT983271E (zh)
RS (1) RS49655B (zh)
SA (1) SA98190179B1 (zh)
SI (1) SI0983271T1 (zh)
SK (1) SK285159B6 (zh)
SV (1) SV1998000057A (zh)
TN (1) TNSN98065A1 (zh)
TR (1) TR199902810T2 (zh)
TW (1) TW480259B (zh)
UA (1) UA56231C2 (zh)
UY (1) UY25004A1 (zh)
WO (1) WO1998052949A1 (zh)
ZA (2) ZA984083B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
EP1905772A1 (en) 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2079741B1 (en) * 2006-09-28 2014-11-26 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
PT2531027E (pt) 2010-01-27 2015-09-16 Viiv Healthcare Co Combinação terapêutica compreendendo dolutegravir, abacavir e lamivudina
WO2012137227A2 (en) 2011-04-08 2012-10-11 Laurus Labs Private Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
EP2962693B1 (en) 2013-02-27 2019-01-09 Kyoto University Pharmaceutical composition comprising abacavir for the treatment of cancer
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
CZ429398A3 (cs) * 1996-06-25 1999-05-12 Glaxo Group Limited Kombinace účinných látek a farmaceutický prostředek

Also Published As

Publication number Publication date
TNSN98065A1 (fr) 2005-03-15
AP9901688A0 (en) 1999-12-31
GB2348202B (en) 2001-08-08
EP0983271B1 (en) 2004-02-18
BRPI9809126B1 (pt) 2018-02-06
CA2289753A1 (en) 1998-11-26
UA56231C2 (uk) 2003-05-15
ES2214712T3 (es) 2004-09-16
SA98190179B1 (ar) 2006-08-15
OA11304A (en) 2003-10-22
MA26498A1 (fr) 2004-12-20
CN1515572A (zh) 2004-07-28
PE78799A1 (es) 1999-08-31
GB2340491B (en) 2000-10-18
DE69821758D1 (de) 2004-03-25
EP0983271A1 (en) 2000-03-08
TW480259B (en) 2002-03-21
UY25004A1 (es) 2000-10-31
BR9809126A (pt) 2000-08-01
PT983271E (pt) 2004-07-30
HUP0002754A3 (en) 2003-01-28
NO324731B1 (no) 2007-12-03
GEP20022680B (en) 2002-04-25
HRP980265A2 (en) 1999-02-28
AR015668A1 (es) 2001-05-16
ID24910A (id) 2000-08-31
EE03924B1 (et) 2002-12-16
TR199902810T2 (xx) 2000-02-21
DZ2493A1 (fr) 2004-06-20
JO2032B1 (en) 1999-05-15
IL132793A0 (en) 2001-03-19
AU7765598A (en) 1998-12-11
DK0983271T3 (da) 2004-05-10
AU739953B2 (en) 2001-10-25
EG23836A (en) 2007-10-02
NO995622L (no) 2000-01-14
SK285159B6 (sk) 2006-07-07
AR059120A2 (es) 2008-03-12
YU59599A (zh) 2002-08-12
AP2009A (en) 2009-06-26
EE9900537A (et) 2000-06-15
RS49655B (sr) 2007-09-21
NO995622D0 (no) 1999-11-16
CA2289753C (en) 2007-01-23
KR20010012623A (ko) 2001-02-26
HUP0002754A2 (hu) 2001-06-28
NZ500865A (en) 2001-04-27
EA001809B1 (ru) 2001-08-27
HRP980265B1 (en) 2004-10-31
SK156199A3 (en) 2000-07-11
ATE259811T1 (de) 2004-03-15
CN1150194C (zh) 2004-05-19
ZA984083B (en) 1999-11-15
MY120151A (en) 2005-09-30
PL189527B1 (pl) 2005-08-31
JP2000327679A (ja) 2000-11-28
JP3150711B2 (ja) 2001-03-26
BRPI9809126B8 (pt) 2021-07-06
NZ510622A (en) 2002-04-26
DE69821758T2 (de) 2005-01-13
GB9709945D0 (en) 1997-07-09
GB0010222D0 (en) 2000-06-14
IS2207B (is) 2007-02-15
CO4940435A1 (es) 2000-07-24
HK1024236A1 (en) 2000-10-05
CN1263529A (zh) 2000-08-16
HU226563B1 (en) 2009-04-28
BG103959A (en) 2000-12-29
PA8451301A1 (es) 2000-05-24
GB2348202A (en) 2000-09-27
JP2000514096A (ja) 2000-10-24
GB9926839D0 (en) 2000-01-12
WO1998052949A1 (en) 1998-11-26
ZA984085B (en) 2000-01-26
US6294540B1 (en) 2001-09-25
EA199900944A1 (ru) 2000-06-26
SV1998000057A (es) 1999-03-02
CN100408580C (zh) 2008-08-06
GB2340491A (en) 2000-02-23
BG64390B1 (bg) 2004-12-30
HN1998000071A (es) 1999-03-19
IL132793A (en) 2006-10-31
KR100521292B1 (ko) 2005-10-17
PL336888A1 (en) 2000-07-17
IS5246A (is) 1999-11-11

Similar Documents

Publication Publication Date Title
PL335541A1 (en) Benzoimidazol-2-carbamates for treating viral infections and carcinoma
ZA958686B (en) Viral vectors and use in gene therapy
GB2340491B (en) Carbocyclic nucleoside hemisulfate and its use in treating viral infections
NO984836L (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
BR9707304A (pt) Análogos de nucleosídeos em terapia de combinação de infecções de herpes simples
ZA983740B (en) Novel amidine derivatives and their use in therapy
GB2327504B (en) Improvements in and relating to durometers
SI1040112T1 (en) Imidazonaphthyridines and their use in inducing cytokine biosynthesis
GB9603657D0 (en) Improvements in the treatment of vaginal infections
GB9609789D0 (en) Improvements in and relating to slew devices
HUT74602A (en) Skin softener and recuperative ointment with quick effect
GB9702184D0 (en) Improvements in or relating to nucleoside and nucleotide analogues
SI0876146T1 (en) Nucleoside analogs in combination therapy of herpes simplex infections
GB9725480D0 (en) Cytokines and their use in the treatment of established chronic infections and cancers
GB9725687D0 (en) Improvements in and relating to bioremediation
KR970051576U (ko) 차량후미의 좌우이동장치
BR7402393U (pt) Aperfeiçoamento introduzido em manta termo-formável
AU139856S (en) Left and right hand rack pair set
BR7701464U (pt) Disposição introduzida em imobilizador de carga em carroceria
GB9724752D0 (en) Improvements in the holding and control of hedgecutters
GB9707589D0 (en) Improvements in and relating to treatment
BR7400054U (pt) Disposição introduzida em carrinho de mão
BR7402137U (pt) Disposição introduzida em porta-moedas